4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-041635
President and CEO sold 3,538 shares at $1.72 ($6,085)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-05 | Sale : show line 1 in the form 10b5-1 | −3,538 | $1.72 | $6,085 | 805,740 | D |
| Open-market sales · 3,538 sh · avg $1.72 · $6,085 | ||||||
Loading xslF345X04/doc4.xml…